JP7766950B2 - Pharmaceutical sales management system - Google Patents

Description

The present invention relates to a pharmaceutical sales management system. Specifically, it relates to a pharmaceutical sales management system that can record pharmaceuticals sold and display precautions for those pharmaceuticals.

Among commercially available pharmaceuticals, prescription drugs and Category 1 drugs are required to be provided with information about the drug and guidance based on pharmaceutical knowledge in person by a pharmacist at the time of sale. When providing this information, pharmaceutical sellers must present explanatory information about the drug to the target customer, such as a checklist, and keep and manage records of this information.
Several such systems have been considered (see, for example, Patent Documents 1 and 2).

Utility Model Registration No. 3150049 JP 2010-170218 A

Patent Document 1 describes an information provision system that reads barcodes attached to pharmaceutical products and displays corresponding usage precautions on a screen. Patent Document 2 describes a sales processing device that uses a scanner to read codes attached to products and prints instructions if necessary.

As described in Patent Documents 1 and 2, systems for displaying pharmaceutical instruction manuals have been considered, but no record is kept of whether or not a pharmacist has provided guidance, making it impossible to determine whether guidance has been provided. The present invention was made in light of the above issues, and aims to provide a pharmaceutical sales management system that records pharmaceuticals sold by pharmacists, presents precautions for those pharmaceuticals, and displays and records information for considering combinations with other pharmaceuticals, etc.

The present invention is as follows.
1. A pharmacist identification information acquisition means for acquiring identification information of a pharmacist who provides instruction on the use of medicines;
A drug identification information acquisition means for acquiring identification information of one or more of the drugs to be sold;
an explanation information acquisition means for acquiring explanation information corresponding to the identification information of each drug obtained by the drug identification information acquisition means;
an explanatory information presenting means for presenting the explanatory information of the drug acquired by the explanatory information acquiring means to a sales target of the drug;
a presentation confirmation means for allowing the target person to confirm the explanatory information of the drug presented by the explanatory information presentation means;
a history storage means for recording sales history information, including the drug identification information obtained by the drug identification information obtaining means, the sales date and time determined from the current date and time, and the pharmacist identification information obtained by the pharmacist identification information obtaining means, in a history database after confirmation by the presentation confirmation means;
A pharmaceutical sales management system comprising:
2. The pharmaceutical sales management system according to 1., wherein the pharmaceutical identification information acquisition means acquires the pharmaceutical identification information by barcode reading means that reads a barcode on which the pharmaceutical identification information is recorded and that is attached to the pharmaceutical.
3. The pharmaceutical sales management system according to 1., wherein the pharmacist identification information acquisition means acquires the pharmacist's identification information by barcode reading means that reads a barcode held by the pharmacist and on which the pharmacist's identification information is recorded.
4. The pharmaceutical sales management system according to 1. above, further comprising a sales target identification information acquisition means for acquiring identification information of the sales target, wherein the history storage means records the sales history information including the sales target identification information acquired by the sales target identification information acquisition means in the history database.
5. The pharmaceutical sales management system according to 4., wherein the identification information of the sales target is an identification number of a member of a store that sells pharmaceuticals.
6. When the barcode reading means reads the identification information of the medicine, the explanation information presenting means determines whether the identification information of the pharmacist has been read,
6. The pharmaceutical sales management system according to any one of 3. to 5., wherein if the reading has been completed, information about the pharmacist is presented to the sales target together with the pharmaceutical explanation information.

This pharmaceutical sales management system can provide sales targets with important information about specific pharmaceuticals sold in stores. It can also record pharmacists who provide face-to-face pharmaceutical instruction using identification information assigned to each pharmacist, allowing for management of the provision of pharmaceutical information and instruction based on pharmaceutical knowledge. Pharmacists can also refer to the history database to confirm which pharmaceuticals are being used by sales targets. This information can then be referenced and used by pharmacists to provide instruction to ensure the more appropriate use of over-the-counter pharmaceuticals.

The present invention will be further described in the following detailed description by way of non-limiting examples of exemplary embodiments according to the present invention and with reference to the mentioned drawings, in which like reference numerals refer to like parts throughout the several views of the drawings.
FIG. 1 is a block diagram for explaining the configuration of the pharmaceutical sales management system. FIG. 10 is a diagram illustrating an example of explanatory information. FIG. 2 is a diagram for explaining the contents of sales history information recorded in a history database. 10 is a flowchart illustrating a process for recording sales history information in a history database. 10 is a flowchart illustrating the flow of the pharmacist identification information acquisition means 11. 10 is a flowchart illustrating the flow of the drug identification information acquisition means 21. 10 is a flowchart illustrating the flow of the explanation information acquisition unit 22. 10 is a flowchart illustrating the flow of a presentation confirmation unit 24. FIG. 10 is a block diagram illustrating the configuration of another pharmaceutical sales management system.

The matters set forth herein are for illustrative purposes only and are intended to provide an illustrative description of embodiments of the present invention, with the objective of providing what is believed to be the most effective and readily understandable explanation of the principles and conceptual features of the present invention. In this regard, it is not intended to show structural details of the present invention beyond those necessary for a fundamental understanding of the present invention, and the description, taken in conjunction with the drawings, will make clear to those skilled in the art how some aspects of the present invention may be implemented in practice.

The present invention will be described in detail below with reference to the drawings.
An embodiment of this pharmaceutical sales management system includes a pharmacist identification information acquisition means 11 that acquires the identification information of a pharmacist who provides pharmaceutical usage instructions, a pharmaceutical identification information acquisition means 21 that acquires the identification information of one or more of the pharmaceuticals to be sold, an explanatory information acquisition means 22 that acquires explanatory information corresponding to the identification information of each pharmaceutical obtained by the pharmaceutical identification information acquisition means 21, an explanatory information presentation means 23 that presents the explanatory information of the pharmaceutical obtained by the explanatory information acquisition means 22 to the person to whom the pharmaceutical is to be sold, a presentation confirmation means 24 that has the person to whom the pharmaceutical is to be sold confirm the explanatory information of the pharmaceutical presented by the explanatory information presentation means 23, and a history storage means 31 that, after confirmation by the presentation confirmation means 24, records sales history information in a history database, including the identification information of the pharmaceutical obtained by the pharmaceutical identification information acquisition means 21, the sales date and time determined from the current date and time, and the identification information of the pharmacist obtained by the pharmacist identification information acquisition means 11.
The system also includes a physical information database 33 that records physical information corresponding to the sales target identification information acquired by the sales target identification information acquisition means, and a physical information display means 34 that displays the sales target's physical information to the pharmacist and/or sales target, and can operate the physical information display means 34 when presented by the presentation confirmation means. Furthermore, the system includes a sales restriction means 35 that determines whether the physical information database 33 and the sales target's physical information and the identification information of other sales targets correspond to the sales restriction information for the sales targets, and notifies the purchaser if they do, and can operate the sales restriction means 35 before the sales target identification information acquisition means 25 operates the history storage means 31.

The pharmaceuticals handled by this pharmaceutical sales management system include at least prescription-only pharmaceuticals and Category 1 pharmaceuticals, etc., which require face-to-face provision of pharmaceutical information by a pharmacist at the time of sale to the intended purchaser. They may also include Category 2 and Category 3 pharmaceuticals, which do not require provision of information, as well as quasi-drugs and health foods.

The pharmacist identification information is information that identifies the pharmacist who provides pharmaceutical instruction and is recorded on an information medium carried by the pharmacist. The pharmacist identification information acquisition means 11 can acquire the pharmacist information about that pharmacist stored in the history database by any reading means from this information medium.
Examples of information media include cards and accessories made of paper or plastic, etc., on which identification information is recorded (examples include one-dimensional barcodes and two-dimensional barcodes), RF chips, characters, magnetic straps, etc. The pharmacist's identification information can be obtained by reading this information media using a reading device such as a barcode reader, magnetic reader, camera, or magnetic card reader. Biometric information such as face, fingerprint, and iris, or password input may also be used. Furthermore, multiple pieces of the above identification information may be combined and used as a whole as a single pharmacist's identification information.
In addition, this system can determine whether the pharmacist identification information is valid using an algorithm or pharmacist identification information stored in a database, and if the pharmacist identification information is invalid, subsequent processing can be stopped.

Drug identification information is information that can individually identify the type of drug being sold. The type of this identification information is not particularly limited, and it may be an existing identification code such as a product code assigned by the drug manufacturer, or it may be a unique code. Drugs may also be identified by product images of the drug.
The drug identification information acquisition means 21 can be configured to determine whether the drug being sold is a specific drug that requires explanation and guidance of precautions to be given to the sales target. At least prescription drugs and first-class drugs are determined to be the specific drug. In addition, the specific drug may include drugs specified by the seller.

The drug information is an explanatory document provided by a pharmacist to the intended recipient, which describes the drug's ingredients, effects, precautions, and confirmation check items, etc. The explanatory document provided to the intended recipient may be the instruction manual attached to the drug, or it may be edited and organized as items requiring explanation and confirmation, or it may include documents, drawings, images, etc. prepared by the seller.
The explanatory information acquisition means 22 is only required to acquire explanatory information of a drug corresponding to the drug identification information, and can acquire the explanatory information of a drug, for example, by referring to a drug database 26 in which drug identification information and corresponding drug explanatory information are recorded. Alternatively, the means 22 can acquire the explanatory information of a drug by referring to an external database or by individually referring to a database for each drug of a drug manufacturer or the like.

The explanatory information presentation means 23 can process the pharmaceutical explanatory information acquired from the explanatory information acquisition means 22 into a form that can be presented. For example, it can change the scale to match the vertical and horizontal dimensions of the display means, such as a display, used to present the pharmaceutical explanatory information; adjust the font size and layout to match the viewing distance; add buttons, etc., to sequentially display explanatory information for multiple pharmaceuticals; provide marking display and operation, such as highlighting important points, for the target sales person; add supplementary information to specific keywords or symbols in the pharmaceutical explanatory information tailored to the target sales person; and add date and time calculations, etc.

When barcodes are used as the pharmacist identification information and drug identification information, any barcode (not limited to striped one-dimensional codes, but including two-dimensional codes) can be used. Furthermore, the same type of barcode can be used for the pharmacist identification information and drug identification information. When the same type of barcode is used, each barcode can be acquired by a different barcode reading means, or by a single barcode reading means. When acquired by a single barcode reading means, the order in which each piece of identification information is acquired can be determined and acquired sequentially, thereby acquiring the pharmacist identification information and drug identification information sequentially. Alternatively, an identification information determination means 42 can be provided that determines whether the acquired barcode value is pharmacist identification information or drug identification information, and a means corresponding to the determined identification information can be implemented. That is, if the value obtained from the barcode is determined to be pharmacist identification information, the pharmacist identification information acquisition means 11 is implemented; if the value is determined to be drug identification information, the drug identification information acquisition means 21 is implemented; and if neither is determined to be true, a read failure can be reported.

The identification information determination means 42 can determine whether the identification information is pharmacist identification information or drug identification information by using differences in the number of digits of the value consisting of numbers, characters, etc. obtained from the barcode (for example, pharmacist identification information if it is less than a predetermined number of digits, and drug identification information if it is more than the predetermined number of digits), differences in the range of values, differences in error detection codes using check digits, checksums, hash values, etc.

The means for presenting the explanatory information of the drug by the explanatory information presenting means 23 is a means for presenting the explanatory information of the drug as a document or the like to the target person for confirmation, and may be a display means for presentation, such as a display on a terminal such as a tablet or a screen of a cash register, or may be a printing means for printing on paper using a printer or the like so that the printed paper can be presented. In addition, playback by a playback means for audio, video, etc. may be used in combination.
The explanatory information presentation means 23 may further include a presentation confirmation means 24 that can detect whether the target person has confirmed the explanatory information of the drug. The presentation confirmation means 24 can detect whether the target person has confirmed the explanatory information of the drug by inputting an input operation such as pressing a confirmation button provided on a touch panel or button device, inputting a handwritten signature, or reading and identifying an identifiable medium such as a point card or an IC card equipped with an electronic certificate. Furthermore, the confirmation information used in the input operation can be stored in the history storage means 31 as sales history information.

Sales target identification information is information that can identify the sales target of the pharmaceuticals being sold. This information can be a combination of name, address, and telephone number. Sales target identification information can also include the identification number of a member of a store that sells pharmaceuticals, such as a point card or membership app. Furthermore, biometric information such as face, fingerprints, and iris can also be used as sales target identification information.

The sales target identification information acquisition means 25 is a means for acquiring the sales target identification information. The sales target identification information acquisition means 25 can acquire the sales target identification information by obtaining the sales target identification information from any input means such as a terminal touch panel or keyboard, or by acquiring sales target identification information that has already been entered into a POS terminal used for sales. The sales target identification information acquisition means 25 can be implemented at any time up until the sales history information is recorded by the history storage means 31, but can also be implemented simultaneously with the presentation confirmation means 24, for example. When implemented simultaneously, the confirmation information, such as a signature, entered by the presentation confirmation means 24 can be used as sales target identification information, eliminating the need to enter it again.

The sales history information is used to record the sales of pharmaceuticals and to confirm whether information was provided by a pharmacist at the time of sale. The sales history information is also stored in the history database 32 by the history storage means 31, and sales history and guidance can be confirmed by referring to the history database 32.
The sales history information includes at least the drug identification information obtained from the drug identification information acquisition means 21, the date and time of sale determined from the current date and time, and the pharmacist information obtained from the pharmacist identification information acquisition means. It can also include optional information such as sales target identification information, check items entered by the sales target, confirmation information such as a signature, and the price of the drug. Note that when this system handles drugs such as Category 2 and Category 3 OTC drugs for which information provision is not required, or other types of products such as quasi-drugs and health foods, information on the type of product can be included.
The sales history information recorded in the history database 32 can be used to, for example, prevent overdose, the excessive use of medicines, in order to utilize commercially available medicines. Furthermore, since the sales history information can be used as health management information for the target purchaser to check drug combinations, similar to a medicine notebook that records prescribed medicines, the history database 32 can be used as a health management database.
Furthermore, by combining it with a searchable database of over-the-counter drugs and prescription drugs with the same efficacy as the sold drug, it can be used as information for selecting and presenting over-the-counter drugs and prescription drugs with the same efficacy. The above-mentioned use can be used to present over-the-counter drugs instead of prescription drugs. It can also be used by doctors, hospitals, and pharmacies that do not handle over-the-counter drugs to know the efficacy of over-the-counter drugs, or to understand the drug usage status of target customers.

The pharmaceutical sales management system 1 may further include a sales quantity limiting means for limiting the number of pharmaceuticals sold to the same sales target to a certain number. For example, the system may acquire information on the known purchase limit for a pharmaceutical product, calculate the number of pharmaceuticals purchased by the same sales target over a certain period of time from sales history information, and issue a notification if the purchase limit is exceeded. The certain period and the purchase quantity are determined based on restrictions such as the maximum allowable dose of the pharmaceutical product.
If the sales target person identification information has not been acquired when the sales quantity limiting means is implemented, the sales target person identification information acquiring means can be implemented first to acquire the sales target person identification information.
In addition, an equivalent drug presentation means may be provided that refers to an equivalent product database that matches the pharmaceutical product being sold with equivalent pharmaceutical products such as generic pharmaceutical products that have the same efficacy, and presents the equivalent pharmaceutical product information along with the pharmaceutical product description information.

Furthermore, a physical information database 33 may be provided that records physical information corresponding to the sales target identification information acquired by the sales target identification information acquisition means. The physical information database 33 may include any information necessary for determining whether a similar drug to be sold is suitable for sale or whether a drug is contraindicated, such as drug history, age, blood pressure, heart rate, electrocardiogram, basal body temperature (mainly for women), height, waist circumference, weight, body fat percentage, daily energy intake (calorie intake), daily step count, and related history, calculated values such as BMI, allergens that cause allergic diseases, and images of food and drink consumed.
Furthermore, the amount of energy intake can be calculated by analyzing photographs of the food and drink eaten to identify the food and drink and its amount, and then referring to the food and drink recognition information recorded in a database and the energy amount per unit amount.

The physical information database 33 can be used for the physical information display means 34 and the sales restriction means 35. The physical information display means 34 and the sales restriction means 35 can be implemented simultaneously with the explanatory information presentation means and can be implemented simultaneously with the display of explanatory information by the explanatory information presentation means. They can also be implemented by an operator's operation while the explanatory information is being displayed. They can also be implemented when sales target identification information is acquired by implementing the sales target identification information acquisition means. Furthermore, if sales target identification information has not been acquired when the physical information display means 34 and the sales restriction means 35 are implemented, the sales target identification information acquisition means can be implemented first to acquire the sales target identification information.

The physical information display means 34 is a means for displaying the physical information of the sales target to the pharmacist and/or the sales target. The physical information display means 34 acquires physical information corresponding to the sales target information from the physical information database 33 and displays the acquired physical information. The pharmacist can use this physical information to select medicines to sell and to determine whether medicines are contraindicated by referring to the physical information.
It can also be used to make decisions about daily health management and lifestyle-related disease prevention. Furthermore, it can also determine whether the food, drink, or medicine you are purchasing is incompatible with other foods, drinks, or medicines based on images of the food and drink you have eaten and the medicines you are purchasing, and notify the pharmacist. Such notifications can reduce the burden on pharmacists and can be used as educational materials for them.

The sales restriction means 35 is a means for determining whether the physical information of the person to whom the drug is sold and the identification information of other drugs sold correspond to the sales restriction information of the drug sold, and notifies the purchaser if they do.
The sales restriction information of the drug to be sold is information that is linked to the identification information of the corresponding drug and stored in the drug database 26. The sales restriction information can include age restriction information, allergen information, food and beverage information, etc. as restricted physical information.
The age restriction information may include restriction conditions such as being under a certain age or being over a certain age, and restriction content information such as not being able to sell or having parental consent confirmed.
The sales restriction means 35 can issue a notification based on the restriction content information when the medicine to be sold satisfies the restriction conditions of the sales restriction information.
An example of the sales restriction means 35 is to restrict sales by age. The age-based sales restriction can prohibit sales if the customer falls under certain conditions, such as if the customer is under a certain age or over a certain age, or can warn the pharmacist by notifying the customer that parental consent is required. By using these conditions, it is possible to warn the pharmacist when selling adult medicines that cannot be taken by children, emergency contraceptives that require parental consent for minors, and antihistamines that require caution when taken by the elderly.
The parental consent is confirmed by acquiring the parent's identification information through the sales target identification information acquisition means 25 and by inputting the parent's signature through the presentation confirmation means 24.

This pharmaceutical sales management system may be composed of software that runs on a terminal such as a tablet or PC, or it may be a service that runs on a server and can be used from the terminal. The terminal may also be provided as a function of a terminal used for sales, such as a POS terminal.

A specific example of this pharmaceutical sales management system, as shown in FIG. 1, is configured as a program on a mobile terminal such as a tablet terminal, and can be a pharmaceutical sales management system 1 including a pharmacist identification information acquisition means 11, a pharmaceutical identification information acquisition means 21, an explanatory information acquisition means 22, an explanatory information presentation means 23, a presentation confirmation means 24, a sales target identification information acquisition means 25, and a history storage means 31. The system further includes a pharmacist database 12, a pharmaceutical database 26, a history database 32, and a barcode reading means 41. The pharmacist database 12 is a database that records the identification information of all pharmacists who are authorized to sell pharmaceuticals through this pharmaceutical sales management system. If the requested identification information is not included in the pharmacist database 12, it can be determined that the corresponding identification information is not authorized to sell the pharmaceutical. The pharmaceutical database 26 is a database that stores pharmaceutical identification information and corresponding pharmaceutical explanatory information. The pharmaceutical explanatory information is configured by combining one or more documents, such as a checklist document as shown in FIG. 2, pharmaceutical package inserts, and related images. As illustrated in Figure 3, the history database 32 is a database that records information such as the date and time of sale, identification information of the sold drug (the drug name in the item in Figure 3), the quantity of the drug sold, confirmation of the time of purchase of the sold drug, the name of the person to whom the drug was sold (the purchaser name in the item in Figure 3), and pharmacist identification information (the pharmacist name in the item in Figure 3).
A specific example will be described below with reference to the flowchart shown in FIG.

(1) Obtaining pharmacist identification information (Step S01)
This pharmaceutical sales management system first acquires the identification information of the pharmacist making the sale using the pharmacist identification information acquisition means 11, following the flowchart shown in Figure 5. The pharmacist identification information acquisition means 11 acquires the pharmacist identification information in barcode form printed on an information medium such as a nameplate carried by the pharmacist by reading it using the barcode reading means 41, which uses the camera of the mobile terminal (see step S011). The pharmacist identification information acquisition means 11 also checks whether the acquired pharmacist identification information is recorded by referring to the pharmacist database 12, which stores a list of pharmacist identification information (step S012). If the pharmacist identification information is recorded in the pharmacist database 12, the pharmacist identification information is acquired and output to the history storage means 31 (step S013).

(2) Acquiring drug identification type (Step S02)
Next, according to the flowchart shown in Figure 6, the drug identification information acquisition means 21 acquires identification information for the drug to be sold. The drug identification information acquisition means 21 acquires drug identification information consisting of a product code attached to the packaging or the like of the drug to be sold by reading it using the barcode reading means 41 or the like (step S021). The acquired drug identification information is also used by the explanation information acquisition means 22 and the history storage means 31. If there are multiple drugs to be sold and there are unprocessed drugs remaining (see step S022), the drug identification information acquisition means 21 executes step S021 again to sequentially acquire identification information for each drug using the barcode reading means 41. After acquiring drug identification information for all drugs, the explanation information acquisition means 22 is executed.

(3) Obtaining drug description information (step S03)
7, the explanatory information acquisition means 22 acquires explanatory information of the drug corresponding to the drug identification information acquired by the drug identification information acquisition means 21. The explanatory information acquisition means 22 queries the drug database 26 using the drug identification information acquired by the drug identification information acquisition means 21 as a key to acquire explanatory information of the corresponding drug (step S031).
If there are multiple drugs for sale and there is identification information for which corresponding drug description information has not been acquired, step S031 is performed again to acquire all of the drug description information corresponding to each drug (step S032). The description information acquisition means 22 passes all of the acquired drug description information to the description information presentation means 23.

(4) Present explanatory information (step S04)
Next, the explanation information presentation means 23, which has received all of the drug explanation information acquired by the explanation information acquisition means 22, sequentially displays the drug explanation information on a display means such as a touch panel display of the terminal. In addition, the explanation information presentation means 23 processes the drug explanation information so that it can be displayed on the display means when it is displayed.
At this time, the pharmacist selling the product can present the displayed one or more pieces of pharmaceutical information to the sales target and provide an explanation and guidance on the pharmaceutical product.

(5) Confirmation of presentation of explanatory information (step S05)
8, the explanatory information presenting means 23 displays the explanatory information for each drug, and then the presentation of the explanatory information is confirmed by the presentation confirmation means 24. The pharmacist asks the sales target to confirm the drug explanatory information. The sales target performs the confirmation operation by operating the confirmation button displayed on the touch panel display or the button on the terminal (step S051).
The presentation confirmation means 24 detects that a confirmation operation has been performed, and if the operation is canceled without performing the confirmation operation, the sale is discontinued and no history is registered (step S052). Also, if unconfirmed drug description information remains, step S051 is performed again for the next drug description information (step S053). When the confirmation operation has been performed for all drug description information, the sales target identification information acquisition means 25 acquires sales target identification information.
The sales target identification information acquisition means 25 acquires the sales target identification information by inputting the sales target's signature via the terminal's touch panel or by inputting the sales store's membership number (step S054), and then executes the history storage means 31.

(6) Recording sales history (step S06)
The history storage means 31 acquires pharmacist identification information using the pharmacist identification information acquisition means 11, acquires drug identification information using the drug identification information acquisition means 21, acquires information on confirmation of presentation of explanatory information using the presentation confirmation means 24, and acquires target sales person identification information using the target sales person identification information acquisition means 25. Then, the history storage means 31 records sales history information in the history database 32 (see FIG. 3 ), including the pharmacist identification information (pharmacist name in FIG. 3 ), drug identification information (drug name in FIG. 3 ), drug quantity information (quantity in FIG. 3 ) obtained by aggregating the input drug identification information, explanation information confirmation (confirmation at the time of sale in FIG. 3 ), target sales person identification information (purchaser name in FIG. 3 ), and date and time of sale (current date and time) (see FIG. 3 ).
The pharmaceutical quantity information is the quantity of pharmaceuticals sold. The pharmaceutical quantity information and the sales target identification information are obtained from the POS terminal used for the sale or from an input means such as a touch panel of the pharmaceutical sales management system 1.

As another specific example of this pharmaceutical sales management system, a pharmaceutical sales management system 1a will be described below, which includes a physical information database 33, a physical information display means 34, and a sales restriction means 35 in addition to the components of the pharmaceutical sales management system 1 shown in Figure 1, as shown in Figure 9.
The physical information database 33 is a database that stores the sales target person's identification information and physical information of the sales target person. It also stores information such as age as physical information. Furthermore, the pharmaceutical database 26 stores sales restriction information corresponding to the pharmaceutical identification information. The stored sales restriction information includes the age range for which sales are restricted and the details of the sales restriction. The details of the sales restriction also include details that restrict sales when the age included in the sales target person's physical information falls within the age range, or details that restrict sales only with parental consent.

(7) Information on the Sales Target The pharmaceutical sales management system 1a can display the physical information of the sales target using the physical information display means 34. The physical information display means 34 is executed by operating the "Confirm Personal Data" button, which is an execution button of the physical information display means 34 and is displayed when the explanation information is confirmed and displayed by the presentation confirmation means 24 (step S05) (see FIG. 2).
The physical information display means 34, which is executed by operating the button, acquires the sales target person identification information using the sales target person identification information acquisition means 25, as in step S054, and then acquires the physical information corresponding to the sales target person identification information acquired from the physical information database 33. The acquired physical information is then displayed. Thereafter, when an operation to end the display of the physical information is performed, the display returns to the confirmation display of the explanatory information by the presentation confirmation means 24 (step S05).

(8) Sales Restrictions The pharmaceutical sales management system 1a can implement sales restrictions based on the physical information of the sales target person using the sales restriction means 35. The sales restriction means 35 is implemented after the confirmation display of the explanatory information by the presentation confirmation means 24 (step S05) is confirmed.
As in step S054, sales restriction means 35 acquires sales target person identification information using sales target person identification information acquisition means 25. Thereafter, sales restriction means 35 acquires physical information corresponding to the acquired sales target person identification information using physical information database 33.
Furthermore, the sales restriction means 35 acquires sales restriction information corresponding to each piece of drug identification information from the drug database 26 .
The system then compares the physical information with all the acquired restriction information to see if it applies, and if it does, displays that fact. Furthermore, the system can suspend sales or obtain parental consent in accordance with the content of the sales restrictions in the sales restriction information.

For example, if the pharmaceutical product is an emergency contraceptive, the sales restriction means 35 determines whether the age in the physical information included in the restriction information indicates that the person is a minor. If the age indicates that the person is a minor, the means 35 then seeks parental consent. If parental consent is subsequently obtained, the sale continues and the sales history is recorded. On the other hand, if consent is not obtained, the means 35 halts the sale and notifies the person accordingly.

By performing the above procedure, the pharmaceutical sales management system 1 can store in a history database a one-to-one record of which pharmacist explained which pharmaceuticals are being sold, allowing for accurate management of the sales history of pharmaceutical instruction and sales by pharmacists.

The present invention is not limited to the specific embodiments described above, and various modifications within the scope of the present invention are possible depending on the purpose and application.

1, 1a; Pharmaceutical sales management system,
11; pharmacist identification information acquisition means, 12; pharmacist database,
21; drug identification information acquisition means, 22; explanation information acquisition means, 23; explanation information presentation means, 24; presentation confirmation means, 25; sales target identification information acquisition means, 26; drug database,
31; history storage means; 32; history database; 33; physical information database; 34; physical information display means; 35; sales regulation means;
41: Barcode reading means, 42: Identification information determining means.

Claims (6)

a pharmacist identification information acquisition means for acquiring identification information of a pharmacist who provides instruction on the use of medicines;
A drug identification information acquisition means for acquiring identification information of one or more of the drugs to be sold;
an explanation information acquisition means for acquiring explanation information corresponding to the identification information of each drug obtained by the drug identification information acquisition means;
an explanatory information presenting means for presenting the explanatory information of the drug acquired by the explanatory information acquiring means to a sales target of the drug;
a presentation confirmation means for causing the target person to confirm the explanatory information of the drug presented by the explanatory information presentation means;
a history storage means for recording sales history information in a history database, the sales history information including the drug identification information obtained by the drug identification information acquisition means, the sales date and time determined from the current date and time, and the pharmacist identification information obtained by the pharmacist identification information acquisition means, after the confirmation operation of the explanatory information by the presentation confirmation means is performed; and
A pharmaceutical sales management system comprising: The pharmaceutical sales management system of claim 1, wherein the pharmaceutical identification information acquisition means acquires the pharmaceutical identification information using a barcode reading means that reads a barcode attached to the pharmaceutical on which the pharmaceutical identification information is recorded. The pharmaceutical sales management system of claim 1, wherein the pharmacist identification information acquisition means acquires the pharmacist's identification information using a barcode reading means that reads a barcode held by the pharmacist on which the pharmacist's identification information is recorded. The pharmaceutical sales management system of claim 1 further comprises a sales target identification information acquisition means for acquiring the identification information of the sales target, and the history storage means records the sales history information, including the sales target identification information acquired by the sales target identification information acquisition means, in the history database. The pharmaceutical sales management system of claim 4, wherein the identification information of the sales target is the identification number of a member of a store that sells pharmaceuticals. the explanation information presenting means, when reading the identification information of the medicine by the barcode reading means, determines whether the identification information of the pharmacist has been read;
The pharmaceutical sales management system according to claim 3, wherein if the information has been read, the information on the pharmacist is presented to the sales target together with the pharmaceutical explanation information.